Chiang Kyle 4
4 · LogicBio Therapeutics, Inc. · Filed Feb 25, 2021
Insider Transaction Report
Form 4
Chiang Kyle
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-23+155,701→ 155,701 totalExercise: $7.76Exp: 2031-02-23→ Common Stock (155,701 underlying)
Footnotes (1)
- [F1]25% vests on 01/01/2022 and the remainder vests in equal monthly installments over the next 36 months.